Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
Purpose of Review: Advances in pharmacogenomics have paved the way for personalized medicine. Cardiovascular diseases still represent the leading cause of mortality in the world. The aim of this review is to summarize the background, rationale, and evidence of pharmacogenomics in cardiovascular medi...
Main Authors: | Alfredo Mauriello, Antonia Ascrizzi, Riccardo Molinari, Luigi Falco, Alfredo Caturano, Antonello D’Andrea, Vincenzo Russo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/14/11/2057 |
Similar Items
-
Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation
by: Luigi Falco, et al.
Published: (2023-05-01) -
Pharmacogenomics in practice: a review and implementation guide
by: Danya Kabbani, et al.
Published: (2023-05-01) -
Statistical and computational pharmacogenomics /
by: 385533 Wu, Rongling, et al.
Published: (2009) -
Principles of pharmacogenetics and pharmacogenomics /
by: Altman, Russ B. 205766, et al.
Published: (2012) -
Handbook of pharmacogenomics and stratified medicines /
by: Padmanabhan, Sandosh, editor
Published: ([201)